Quantification of renal haemodynamics with radio-nuclides
ABSTRACT Non-invasive quantification of renal function with radionuclides is an important role of nuclear medicine. With modern commercial preparations of technetium-99m diethylene triamine penta-acetic acid (DTPA), glomerular filtration rate (GFR) can be measured accurately either from the rate of disappearance of the tracer from plasma or from its rate of uptake into the kidneys. Determination of the latter with the gamma camera allows measurement of individual kidney GFR. Renal blood flow (RBF) can be measured from plasma clearance of hippurate or from first-pass kinetics of intravenously injected tracer using the gamma camera. The filtration fraction can be obtained from separate measurement of GFR and RBF, either globally from plasma clearance studies or of each kidney from gamma camera studies. Because they are central to the understanding of plasma clearance studies, the effective distribution volumes of the various tracers used for renal function studies are also discussed in detail.
- SourceAvailable from: slu.se
Article: Renal scintigraphy in dogs[Show abstract] [Hide abstract]
ABSTRACT: Renal scintigraphy has been used widely to measure the individual kidney glomerular filtration rate (IKGFR). In dogs, the estimated GFR is calculated by a regression equation relating the percent of the injected dose of radiopharmaceutical, technetium-99m DTPA (dietylene-triaminepentaacetic acid), taken up by the kidneys to the known GFR by standard (plasma) clearance normalized to bodyweight (BW). Uptake is calculated by the integral (area under the curve) of time activity curve (TAC) of the renogram, which is corrected for attenuation of radiation in the body from kidneys to body surface of the back and background activity. A more physiologically correct method is to normalize GFR to plasma volume (GFR/PV), which requires a region of interest (ROI) of the left ventricle (LV). The first aim of the thesis was to determine the variations within the standard method and minimize them to improve the accuracy of the methods. Physiological variability of GFR within and among dogs on different days was also studied. The integral method was more stable than a slope method and recommended to used for calculating IKGFR/BW. The best methods for measuring were: semi-automatic drawing of kidney ROI with 20% threshold, a perirenal background ROI at one pixel wide and one pixel out from kidney ROI, a threshold color scale rather than continuous for measuring kidney depth to calculate attenuation, and a time interval between 30 – 120 seconds from the start of the TAC. Measurement variation was also caused by significant observer variability, which indicates that methods must be standardized and the same person should measure all compared results. Physiologic day-to-day variability of GFR in normal dogs was mostly found between rather than within dogs, and accounted for most of the variability. GFR/PV was not affected by LV ROI sizes. Subtracting extravascular activity from the LV ROI did not improve precision, but increased variability due to different LV ROI sizes and time intervals chosen for LV plot. Manual LV ROI, without extravascular subtraction and a time interval for LV input between 1 and 4 minutes are recommended.
- [Show abstract] [Hide abstract]
ABSTRACT: The current methods for the estimation of glomerular filtration rate (GFR) in small animals are limited by inaccuracy, complexity and invasiveness [1, 2]. To avoid the need for constant infusion or urine collection and to improve accuracy, techniques using a single intravenous injection of radioisotope have been developed to estimate GFR [1–3]. The accuracy of these techniques, however, is reduced by errors involving isotope extravasation during tail vein injection and assumptions about the volume of distribution required for the calculation of GFR from a single blood sample . Hence, to overcome these problems we have developed and validated a simple noninvasive technique employing a single intraperitoneal injection of 99mTc diethylenetriaminepentaacetic acid (DTPA) and two timed blood samples.Kidney International 03/1992; 41(2):450-4. DOI:10.1038/ki.1992.63 · 8.52 Impact Factor
- Critical Reviews in Oncology/Hematology 12/1992; 13(3):215-40. DOI:10.1016/1040-8428(92)90091-4 · 4.05 Impact Factor